Many autistic people use cannabis to improve quality of life by promoting both mental and physical wellness, but until recently, there has been limited scientific representation of this lived experience. This course will cover the emerging scientific evidence of both hemp (high CBD) and high-THC cannabis with a special focus on the lesser known rare cannabinoids in the context of neurodivergent brains. We will focus on endocannabinoid system and serotonin system pharmacology and will also discuss how cannabis can be leveraged to potentiate the therapeutic benefits of classic serotonergic psychedelics.

The course will be split into seven lectures:

  1. The Endocannabinoid System & Clinical Endocannabinoid Deficiency

  2. Cannabinoids, Terpenes, and the Importance of  Chemodiversity

  3. Sensory Hypersensitivity & Chronic Pain

  4. Gastrointestinal Issues

  5. Baseline Anxiety & Sleep

  6. Socioemotional Regulation & Relationships

  7. Psychedelic Synergy


The world’s first online co-learning community dedicated to remaining hyper-focused on the intersection of psychedelics & neurodivergence.

Founded in 2020, the APC offers peer-supported psychedelic integration for those navigating autism, ADHD & other neurological variations.

Psychedelics aside, we also welcome anyone, of any neurotype, to join us for open discussions hosted in alignment with the neurodiversity paradigm.

To RSVP for a meeting, click here, or go to our website ( to listen, watch, and read our stories 🙂

"Cannabis and cannabinoids have very promising effects in the treatment of autistic symptoms and can be used in the future as an important therapeutic alternative to relieve those symptoms, especially bouts of self-mutilation and anger, hyperactivity, sleep problems, anxiety, restlessness, psychomotor agitation, irritability, and aggressiveness; as well as improve sensory sensitivity, cognition, attention, social interaction, language, perseverance, and depression."